-
1 Comment
Artemis Medicare Services Limited is currently in a long term uptrend where the price is trading 66.7% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the sector with a price to sales ratio of 0.0.
Based on the above factors, Artemis Medicare Services Limited gets an overall score of 2/5.
Industry | |
---|---|
Exchange | NSE |
CurrencyCode | INR |
ISIN | INE025R01021 |
Sector |
Target Price | 385 |
---|---|
Dividend Yield | 0.0% |
Market Cap | None |
PE Ratio | 109.5 |
Beta | 0.28 |
Artemis Medicare Services Limited engages in the management and operation of multi specialty hospitals in India and internationally. The company offers medical and surgical intervention; and inpatient and outpatient services. It also operates Artemis Hospital, a multi-specialty hospital located in Gurugram. In addition, the company provides billing and insurance, care pages, child care, emotional and support programs, health services, international patient services, medical interpreter and records services, mind body medicine, nursing, nutrition, patient and family advisory, patient advocacy and portal, pre-admission testing, and smoking cessation programs services; and executive Health Checks workplace clinics for counseling; outpatient and hospitalization services; healthcare education and awareness programs; first aid and BLS training; emergency services; and organizational healthcare audit services. Artemis Medicare Services Limited was incorporated in 2004 and is based in Gurugram, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ARTEMISMED.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025